Linagliptin N-Acetyl Impurity
|
|
- CAS-Nr.
- 1803079-49-3
- Englisch Name:
- Linagliptin N-Acetyl Impurity
- Synonyma:
- Linagliptin F;Linagliptin Impurity 34;Linagliptin impurity 02;Linagliptin N-Acetyl imp;LIGLIPTIN N-ACETYL IMPURITY;Linagliptin ImpurityD10088;Linagliptin N-Acetyl Impurity;Linagliptin N-Acetyl Impurity/ Linagliptin acetamide;tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-6-oxo-6,7-dihydro-3H-purin-8-yl)piperidin-3-yl)carbamate;N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]acetamide
- CBNumber:
- CB63363760
- Summenformel:
- C27H30N8O3
- Molgewicht:
- 514.58
- MOL-Datei:
- 1803079-49-3.mol
|
Linagliptin N-Acetyl Impurity Eigenschaften
- Dichte
- 1.37±0.1 g/cm3(Predicted)
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
- Aggregatzustand
- Solid
- pka
- 15.70±0.20(Predicted)
- Farbe
- Light Yellow to Yellow
Sicherheit
Linagliptin N-Acetyl Impurity Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Linagliptin Acetamide is an impurity of linagliptin (L465900), which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
Linagliptin N-Acetyl Impurity Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Linagliptin N-Acetyl Impurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 53)Lieferanten
- Linagliptin F
- tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-6-oxo-6,7-dihydro-3H-purin-8-yl)piperidin-3-yl)carbamate
- (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide (Linagliptin Impurity)
- Linagliptin N-Acetyl imp
- Linagliptin N-Acetyl Impurity/ Linagliptin acetamide
- Linagliptin Impurity 34
- Linagliptin N-Acetyl Impurity
- N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]acetamide
- Linagliptin impurity 11/(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
- Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-
- LIGLIPTIN N-ACETYL IMPURITY
- Linagliptin impurity 02
- Linagliptin ImpurityD10088
- 1803079-49-3
- C27H30N8O3